Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome

Dominic E Cosgrove, Daniel T. Meehan, James A. Grunkemeyer, Jody M. Kornak, Robinlyn Sayers, William J. Hunter, Gina C. Samuelson

Research output: Contribution to journalArticle

248 Citations (Scopus)

Abstract

A mouse model for the autosomal form of Alport syndrome was produced. These mice develop a progressive glomerulonephritis with microhematuria and proteinuria, consistent with the human disease. End-stage renal disease develops at ~14 weeks of age. TEM analysis of the glomerular basement membranes (GBM) during development of renal pathology revealed focal multilaminated thickening and thinning beginning in the external capillary loops at 4 weeks and spreading throughout the GBM by 8 weeks. By 14 weeks, half of the glomeruli were fibrotic with collapsed capillaries. Immunofluorescence analysis of the GBM showed the absence of type IV collagen α-3, α-4, and α-5 chains and a persistence of α-1 and α-2 chains (these chains normally localize to the mesangial matrix). Northern blot analysis using probes specific for the collagen chains illustrate the absence of COL4A3 in the knockout, whereas mRNAs for the remaining chains are unchanged. An accumulation of fibronectin, heparan sulfate proteoglycan, laminin-1, and entactin was observed in the GBM of the affected animals. The temporal and spatial pattern of accumulation was consistent with that for thickening of the GBM as observed by TEM. Thus, expression of these basement membrane- associated proteins may be involved in the progression of Alport renal disease pathogenesis. The levels of mRNAs encoding the basement membrane- associated proteins at 7 weeks were unchanged.

Original languageEnglish (US)
Pages (from-to)2981-2992
Number of pages12
JournalGenes and Development
Volume10
Issue number23
DOIs
StatePublished - Jan 1 1996

Fingerprint

Hereditary Nephritis
Glomerular Basement Membrane
Knockout Mice
Collagen
Basement Membrane
Membrane Proteins
Kidney
Heparan Sulfate Proteoglycans
Messenger RNA
Collagen Type III
Glomerulonephritis
Proteinuria
Fibronectins
Northern Blotting
Chronic Kidney Failure
Fluorescent Antibody Technique
Pathology

Keywords

  • Alport syndrome
  • Basement membrane
  • mouse model

ASJC Scopus subject areas

  • Genetics
  • Developmental Biology

Cite this

Cosgrove, D. E., Meehan, D. T., Grunkemeyer, J. A., Kornak, J. M., Sayers, R., Hunter, W. J., & Samuelson, G. C. (1996). Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes and Development, 10(23), 2981-2992. https://doi.org/10.1101/gad.10.23.2981

Collagen COL4A3 knockout : A mouse model for autosomal Alport syndrome. / Cosgrove, Dominic E; Meehan, Daniel T.; Grunkemeyer, James A.; Kornak, Jody M.; Sayers, Robinlyn; Hunter, William J.; Samuelson, Gina C.

In: Genes and Development, Vol. 10, No. 23, 01.01.1996, p. 2981-2992.

Research output: Contribution to journalArticle

Cosgrove, DE, Meehan, DT, Grunkemeyer, JA, Kornak, JM, Sayers, R, Hunter, WJ & Samuelson, GC 1996, 'Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome', Genes and Development, vol. 10, no. 23, pp. 2981-2992. https://doi.org/10.1101/gad.10.23.2981
Cosgrove DE, Meehan DT, Grunkemeyer JA, Kornak JM, Sayers R, Hunter WJ et al. Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome. Genes and Development. 1996 Jan 1;10(23):2981-2992. https://doi.org/10.1101/gad.10.23.2981
Cosgrove, Dominic E ; Meehan, Daniel T. ; Grunkemeyer, James A. ; Kornak, Jody M. ; Sayers, Robinlyn ; Hunter, William J. ; Samuelson, Gina C. / Collagen COL4A3 knockout : A mouse model for autosomal Alport syndrome. In: Genes and Development. 1996 ; Vol. 10, No. 23. pp. 2981-2992.
@article{5d89d0cdfdd644c39cd19eeee041f8ac,
title = "Collagen COL4A3 knockout: A mouse model for autosomal Alport syndrome",
abstract = "A mouse model for the autosomal form of Alport syndrome was produced. These mice develop a progressive glomerulonephritis with microhematuria and proteinuria, consistent with the human disease. End-stage renal disease develops at ~14 weeks of age. TEM analysis of the glomerular basement membranes (GBM) during development of renal pathology revealed focal multilaminated thickening and thinning beginning in the external capillary loops at 4 weeks and spreading throughout the GBM by 8 weeks. By 14 weeks, half of the glomeruli were fibrotic with collapsed capillaries. Immunofluorescence analysis of the GBM showed the absence of type IV collagen α-3, α-4, and α-5 chains and a persistence of α-1 and α-2 chains (these chains normally localize to the mesangial matrix). Northern blot analysis using probes specific for the collagen chains illustrate the absence of COL4A3 in the knockout, whereas mRNAs for the remaining chains are unchanged. An accumulation of fibronectin, heparan sulfate proteoglycan, laminin-1, and entactin was observed in the GBM of the affected animals. The temporal and spatial pattern of accumulation was consistent with that for thickening of the GBM as observed by TEM. Thus, expression of these basement membrane- associated proteins may be involved in the progression of Alport renal disease pathogenesis. The levels of mRNAs encoding the basement membrane- associated proteins at 7 weeks were unchanged.",
keywords = "Alport syndrome, Basement membrane, mouse model",
author = "Cosgrove, {Dominic E} and Meehan, {Daniel T.} and Grunkemeyer, {James A.} and Kornak, {Jody M.} and Robinlyn Sayers and Hunter, {William J.} and Samuelson, {Gina C.}",
year = "1996",
month = "1",
day = "1",
doi = "10.1101/gad.10.23.2981",
language = "English (US)",
volume = "10",
pages = "2981--2992",
journal = "Genes and Development",
issn = "0890-9369",
publisher = "Cold Spring Harbor Laboratory Press",
number = "23",

}

TY - JOUR

T1 - Collagen COL4A3 knockout

T2 - A mouse model for autosomal Alport syndrome

AU - Cosgrove, Dominic E

AU - Meehan, Daniel T.

AU - Grunkemeyer, James A.

AU - Kornak, Jody M.

AU - Sayers, Robinlyn

AU - Hunter, William J.

AU - Samuelson, Gina C.

PY - 1996/1/1

Y1 - 1996/1/1

N2 - A mouse model for the autosomal form of Alport syndrome was produced. These mice develop a progressive glomerulonephritis with microhematuria and proteinuria, consistent with the human disease. End-stage renal disease develops at ~14 weeks of age. TEM analysis of the glomerular basement membranes (GBM) during development of renal pathology revealed focal multilaminated thickening and thinning beginning in the external capillary loops at 4 weeks and spreading throughout the GBM by 8 weeks. By 14 weeks, half of the glomeruli were fibrotic with collapsed capillaries. Immunofluorescence analysis of the GBM showed the absence of type IV collagen α-3, α-4, and α-5 chains and a persistence of α-1 and α-2 chains (these chains normally localize to the mesangial matrix). Northern blot analysis using probes specific for the collagen chains illustrate the absence of COL4A3 in the knockout, whereas mRNAs for the remaining chains are unchanged. An accumulation of fibronectin, heparan sulfate proteoglycan, laminin-1, and entactin was observed in the GBM of the affected animals. The temporal and spatial pattern of accumulation was consistent with that for thickening of the GBM as observed by TEM. Thus, expression of these basement membrane- associated proteins may be involved in the progression of Alport renal disease pathogenesis. The levels of mRNAs encoding the basement membrane- associated proteins at 7 weeks were unchanged.

AB - A mouse model for the autosomal form of Alport syndrome was produced. These mice develop a progressive glomerulonephritis with microhematuria and proteinuria, consistent with the human disease. End-stage renal disease develops at ~14 weeks of age. TEM analysis of the glomerular basement membranes (GBM) during development of renal pathology revealed focal multilaminated thickening and thinning beginning in the external capillary loops at 4 weeks and spreading throughout the GBM by 8 weeks. By 14 weeks, half of the glomeruli were fibrotic with collapsed capillaries. Immunofluorescence analysis of the GBM showed the absence of type IV collagen α-3, α-4, and α-5 chains and a persistence of α-1 and α-2 chains (these chains normally localize to the mesangial matrix). Northern blot analysis using probes specific for the collagen chains illustrate the absence of COL4A3 in the knockout, whereas mRNAs for the remaining chains are unchanged. An accumulation of fibronectin, heparan sulfate proteoglycan, laminin-1, and entactin was observed in the GBM of the affected animals. The temporal and spatial pattern of accumulation was consistent with that for thickening of the GBM as observed by TEM. Thus, expression of these basement membrane- associated proteins may be involved in the progression of Alport renal disease pathogenesis. The levels of mRNAs encoding the basement membrane- associated proteins at 7 weeks were unchanged.

KW - Alport syndrome

KW - Basement membrane

KW - mouse model

UR - http://www.scopus.com/inward/record.url?scp=0029829425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029829425&partnerID=8YFLogxK

U2 - 10.1101/gad.10.23.2981

DO - 10.1101/gad.10.23.2981

M3 - Article

C2 - 8956999

AN - SCOPUS:0029829425

VL - 10

SP - 2981

EP - 2992

JO - Genes and Development

JF - Genes and Development

SN - 0890-9369

IS - 23

ER -